Trial Profile
Phase I/II trial of chemoradiotherapy concurrent with Satraplatin in renal impairment patients with squamous cell carcinoma of the head and neck
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 28 Sep 2018
Price :
$35
*
At a glance
- Drugs Satraplatin (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Yakult Honsha
- 25 May 2016 New trial record